California Specialty Pharmacy, Inc., Whittier, CA

Is California Specialty Pharmacy, Inc. registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does California Specialty Pharmacy, Inc. hold a California pharmacy license?

The California State Board of Pharmacy lists 2 licenses for this name and city, as of Nov 6, 2026: LSC 102144 for California Specialty Pharmacy Llc, Whittier, status Active and PHY 61706 for California Specialty Pharmacy Llc, Whittier, status Active. The Colorado State Board of Pharmacy also lists nonresident license OSP 6033 for California Specialty Pharmacy LLC, Whittier, CA, status Active, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054017519 for CALIFORNIA SPECIALTY PHARMACY, WHITTIER, CA, status NOT RENEWED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0003890 for CALIFORNIA SPECIALTY PHARMACY, Whittier, CA, status ACTIVE (CURRENT), as of Nov 15, 2026.

Has California Specialty Pharmacy, Inc. had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (May 20, 2020) and 1 FMD-145 letter (Nov 16, 2020) for California Specialty Pharmacy, Inc. State board actions: no California State Board of Pharmacy action on licenses LSC 102144 and PHY 61706 or under this exact name and city was found in the board’s posted disciplinary decisions on facility licenses (actions dated Jan 5, 2005 to Oct 28, 2026) on Nov 6, 2026. The Colorado State Board of Pharmacy’s license dataset also lists “CLS Stipulation” dated Jun 28, 2024, case 2024-2487 on nonresident license OSP 6033.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
California Specialty Pharmacy, Inc.
Location
Whittier, CA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Nov 16, 2020
FDA Data Dashboard inspections
1 inspection: 1 VAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 2 observations
State board records
License found: LSC 102144, Active; PHY 61706, Active

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as California Specialty Pharmacy, Inc., a 503A facility, with 3 dated actions.

Document
Nov 16, 2020FMD-145 letterFMD-145 Letter Issued 11/16/2020Not linked by FDA
May 20, 2020Untitled letterUntitled Letter Issued 05/20/2020fda.gov
May 17, 2019Form 483483 Issued 05/17/2019fda.gov

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists California Specialty Pharmacy Inc., Whittier, CA (FEI number 3015131323), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
May 17, 2019Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30151313231089869

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection May 13, 2019 to May 17, 2019: 2 observations

Firm on the cover
California Specialty Pharmacy Inc., 13027 Hadley St Ste B, Whittier, CA 90601-4206
FEI number
3015131323
Establishment type on the cover
Producer of Non-Sterile Drug Products
FDA district office on the cover
19701 Fairchild Irvine, CA 92612-2445
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You used a non-pharmaceutical grade component in the formulation of a drug product.

Specifically, your firm used components that were not pharmaceutical grade to produce drug products that included, but were not limited to, the items listed below.

A.) Non-pharmaceutical grade <Redacted B4> water was purchased by your firm and it was used to produce multiple nasal spray drug products. Examples include, but are not limited to, the drug products listed below.

l. Approximately <Redacted B4> • lots of C-Ketamine NasaJ Spray were produced between February 2019 and May 2019.

2. Approximately <Redacted B4> lots of C-Oxytocin 24 units/ml Nasal Spray were produced between February 2019 and May 2019.

3. Approximately <Redacted B4> lot of C-Lidocaine HCI 4% Glycerin Nasal Spray was produced in April 2019.

Your firm has not submitted any samples of this <Redacted B4> water to your contract laboratory to test for microbial limits and/or other analytical properties to show it is equivalent to pharmaceutical grade water.

B.) Non-pharmaceutical grade ingredient, Oxytocin, was purchased and used by your firm to produce non-sterile sublingual tablet and non-sterile nasal spray drug products. ...

Read the full 483 (PDF on fda.gov)

Observation 2

You produced hazardous drugs without providing adequate cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.

Specifically, your firm does not have cleaning procedures in place to ensure the prevention of cross-contamination of hazardous drugs. Examples include, but are not limited to, the cleaning of work surfaces, compounding equipment, and utensils, which are located and/or used to produce hazardous drug products in the non-sterile compounding room. Examples of hazardous drug products made at your firm include, but are not limited to, C-Oxytocin Sublingual Tablets and C-Oxytocin Nasal Spray.

State board of pharmacy records

The California State Board of Pharmacy file dated Nov 6, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.

LicenseType as the board gives itName on the board recordCityStatus
LSC 102144Resident Licensed Sterile CompoundingCalifornia Specialty Pharmacy LlcWhittierActive
PHY 61706Retail PharmacyCalifornia Specialty Pharmacy LlcWhittierActive

What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).

LicenseType as the board gives itName on the board recordLocationStatus
OSP 6033OSPCalifornia Specialty Pharmacy LLCWhittier, CAActive

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054017519LICENSED PHARMACYCALIFORNIA SPECIALTY PHARMACYWHITTIER, CANOT RENEWED

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0003890NONRESIDENT PHARMACYCALIFORNIA SPECIALTY PHARMACYWhittier, CAACTIVE (CURRENT)

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.